| Intrinsic Valuation of: CRISIL | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 97 | Market Cap | ₹442B | |||||
| 2021 | - | - (-) | P/E Ratio | 62 | Total Asset | ₹39B | |||||
| 2022 | ₹4B | - (-) | Net Income | ₹7B | Total Debt | ₹0 | |||||
| 2023 | ₹4B | 9.2% (-9.3%) | EBITDA | ₹10B | Total Liab | ₹14B | |||||
| 2024 | ₹7B | 72.8% (52.4%) | Opr Margin | 0.26 | Debt/Equity | - | |||||
| 2025 | ₹6B | -17.5% (-20.5%) | PreTax Margin | 25.69 | BV/Share | 270 | |||||
| 5Y Average FCF | ₹5B | 21.5% (7.5%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (21.5%) | ||||||||||
| 2026 | ₹7B | MBG Intrinsic Value | ₹864 | ||||||||
| 2027 | ₹9B | ||||||||||
| 2028 | ₹11B | ||||||||||
| 2029 | ₹13B | ||||||||||
| 2030 | ₹16B | ||||||||||
| 2031 | ₹19B | ||||||||||
| Terminal Value | ₹396B | Net Worth/Share | ₹351 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹313B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹3B | ₹4,324 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹0 | WACC | 7.3% | 3,771 | 4,065 | 4,419 | 4,856 | 5,407 | |||
| Equity Value | ₹316B | 7.4% | 3,736 | 4,024 | 4,371 | 4,797 | 5,334 | ||||
| Shares Outstanding | 73,130,000 | 7.4% | 3,702 | 3,984 | 4,324 | 4,740 | 5,262 | ||||
| 7.9% | 3,390 | 3,623 | 3,898 | 4,230 | 4,637 | ||||||
| DCF Intrinsic Value | ₹4,324 | 8.4% | 3,123 | 3,318 | 3,545 | 3,815 | 4,139 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||